T1	Limitation 23039 23046	Fourth,
T2	Limitation 23617 23620	Our
T3	Limitation 23903 23910	Second,
T4	Limitation 24607 24613	Fifth,
T5	Population 23047 23100	we did not examine vulnerability to stereotype threat
T6	VerySpecificPopulation 23617 23720	Our study population may represent individuals who are particularly motivated to participate in a trial
T7	ResponsivenessOfMeasurement 23911 23986	our measures of adherence may be insensitive to effects of our intervention
T8	Limitation 24258 24263	Third
T9	Generalization 24432 24479	may not be generalizable to broader populations
T10	DiagnosticCriteria 24265 24363	participants were required to have only 1 elevated BP measure in the prior 12 months for inclusion
T11	Limitation 24481 24487	Fourth
T12	Population 24489 24605	many sociodemographic characteristics of the participants differed yet were balanced within race and treatment group
T13	RelevantOutcomeExcluded 24632 24679	did not measure patient-clinician communication
T14	Limitation 25927 25934	Finally
T15	Intervention 25954 25994	tested only a patient-level intervention
